Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Cash from Investing Activities (2016 - 2018)

Armata Pharmaceuticals (ARMP) has disclosed Cash from Investing Activities for 6 consecutive years, with -$535000.0 as the latest value for Q4 2018.

  • Quarterly Cash from Investing Activities fell 2872.22% to -$535000.0 in Q4 2018 from the year-ago period, while the trailing twelve-month figure was -$597000.0 through Dec 2018, down 929.31% year-over-year, with the annual reading at -$542000.0 for FY2025, 71.15% up from the prior year.
  • Cash from Investing Activities hit -$535000.0 in Q4 2018 for Armata Pharmaceuticals, down from -$11000.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of -$2000.0 in Q2 2017 to a low of -$831000.0 in Q2 2014.
  • Historically, Cash from Investing Activities has averaged -$127500.0 across 5 years, with a median of -$34000.0 in 2015.
  • Biggest five-year swings in Cash from Investing Activities: surged 98.92% in 2015 and later tumbled 2872.22% in 2018.
  • Year by year, Cash from Investing Activities stood at -$5000.0 in 2014, then crashed by 900.0% to -$50000.0 in 2015, then surged by 74.0% to -$13000.0 in 2016, then plummeted by 38.46% to -$18000.0 in 2017, then crashed by 2872.22% to -$535000.0 in 2018.
  • Business Quant data shows Cash from Investing Activities for ARMP at -$535000.0 in Q4 2018, -$11000.0 in Q3 2018, and -$18000.0 in Q4 2017.